Experience Counts

The nation’s leading law firm protecting health plan recovery rights

In every mass tort case for the last 30 years Rawlings & Associates PLLC has represented more health plans and recovered more dollars for the industry than any other law firm. That experience gives us a deep understanding of health plans’ legal and business interests, allowing us to maximize results for our clients while protecting their member relationships.

Our Services

Health Plan Mass Tort Recoveries

Mass torts involving dangerous drugs, medical devices, or defective products impose significant costs on health plans. Rawlings recovers those costs from the companies that caused them, allowing our health plan clients to devote more resources to serving their health plan members.

Representative Mass Tort Cases:

OPIOIDS:

  • In re National Prescription Opiate Litig., 1:17-md-2804 (N.D. Ohio) (MDL 2804)
  • In re Insys Therapeutics, Inc., et al., 19-11292 (Bankr. D. Del.)
  • In re Purdue Pharma L.P., et al., 19-23649 (Bankr. S.D.N.Y.)
  • In re Mallinckrodt PLC, et al., 20-12522 (Bankr. D. Del.)
  • In re Endo International plc, et al., 22-22459 (Bankr. S.D.N.Y.)
  • In re Rite Aid Corporation, et al., 23-18993 (Bankr. D.N.J.)
  • In re McKinsey & Co., Inc. National Prescription Opiate Consultant Litig., 21-md-2996 (N.D. Cal.) (MDL 2996)

ROUNDUP:

  • In re Roundup Prods. Liab. Litig., 3:16-md-2741 (N.D. Cal.) (MDL 2741)

CAMP LEJEUNE:

  • In re Camp Lejeune Water Litig. v. United States., 7:23-cv-00897 (E.D.N.C.)

ALL METAL HIPS:

  • In re DePuy Orthopaedics, Inc. ASR Hip Implant Prods. Liab. Litig., 1:10-md-2197 (N.D. Ohio) (MDL 2197)
  • In re Smith & Nephew Birmingham Hip Resurfacing (BHR) Hip Implant Prods. Liab. Litig., No. 1:17-md-2775 (D. Md.) (MDL 2775)
  • In re Stryker LFIT V40 Femoral Head Prods. Liab. Litig., 1:17-md-2768 (D. Mass.) (MDL 2768)
  • In re Zimmer M/L Taper Hip Prosthesis or M/L Taper Hip Prosthesis with Kinectiv Technology and Versys Femoral Head Prods. Liab. Litig., 1:18-md-2859 (S.D.N.Y.) (MDL 2859)

HERNIA MESH:

  • In re Alloderm Litigation, No. 295, (N.J. Super. Ct.)
  • In re Atrium Medical Corp. C-Qur Mesh Prods. Liab. Litig., 1:16-md-2753 (D.N.H.) (MDL 2753)
  • In re Ethicon Physiomesh Flexible Composite Hernia Mesh Prods. Liab. Litig., 1:17-md-2782 (N.D. Ga.) (MDL 2782)
  • In re Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Prods. Liab. Litig., 2:18-md-2846 (S.D. Ohio) (MDL 2846)
  • In re Covidien Hernia Mesh Prods. Liab. Litig. (No. II), No. 1:22-md-3029 (D. Mass.) (MDL 3029)

HORMONE REPLACEMENT THERAPY:

  • In re: Prempro Products Liability Litigation, 3:10-mc-138 (E.D. Ariz.) (MDL 1507)
  • Premarin:
    –     California:  Blevins, et al. v. Wyeth-Ayerst Laboratories, Inc., et al.
    –     Ohio:  Marjorie Ferrell, et al. v. Wyeth-Ayerst Laboratories, Inc., et al.

MEDTRONIC:

  • In re Medtronic, Inc. Implantable Defibrillators Prods. Liab. Litig., 1:05-md-01726 (D. Minn.) (MDL 1726)

PELVIC MESH:

  • In re Mentor Corp. Obtape Transobturator Sling Prods. Liab. Litig. 4:08-md-2004 (M.D. Ga.) (MDL 2004)
  • In re Avaulta Pelvic Support Sys. Prods. Liab. Litig. (S.D.W. Va.) (MDL 2187)
  • In re C.R. Bard, Inc., Pelvic Repair Sys. Prods. Liab. Litig., 2:10-md-2187 (S.D.W. Va.) (MDL 2187)     
  • In re Am. Med. Sys., Inc., Pelvic Repair Sys. Prods. Liab. Litig., 2:12-md-2325 (S.D.W. Va.) (MDL 2325)
  • In re Boston Scientific Corp. Pelvic Repair Sys. Prods. Liab. Litig., 2:12-md-2326 (S.D.W. Va.) (MDL 2326)
  • In re Ethicon Inc., Pelvic Repair Sys. Prods. Liab. Litig., 2:12-md-2327 (S.D.W. Va.) (MDL 2327)
  • In re Coloplast Corp. Pelvic Support Syst. Prods. Liab. Litig., 2:12-md-2387 (S.D.W. Va.) (MDL 2387)
  • In re Cook Medical, Inc., Pelvic Repair Sys. Prods. Liab. Litig., 2:13-md-2440 (S.D.W. Va.) (MDL 2440)
  • In re Neomedic Pelvic Repair Sys. Prods. Liab. Litig., 2:14-md-2511 (S.D.W. Va.) (MDL 2511)

PHILIPS CPAP:

  • Philips Recalled Cpap, Bi-Level Pap, And Mechanical Ventilator Prods. Liab. Litig., 2:21-mc-1230 (W.D. Pa.) (MDL 3014)

PROTON PUMP INHIBITORS:

  • In re Proton-Pump Inhibitor Prods. Liab. Litig. (No. II), 2:17-md-2789 (D.N.J.) (MDL 2789)

TALC:

  • In re Johnson & Johnson Talcum Powder Prods. Mktg., Sales Practices & Prods. Liab. Litig., 3:16-md-2738 (D.N.J.) (MDL 2738)

XARELTO:

  • In re Xarelto (Rivaroxaban) Prods. Liab. Litig., 2:14-md-2592 (E.D. La.) (MDL 2592)

YAZ:

  • In re Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Prods. Liab. Litig., 3:09-md-2100 (S.D. Ill.) (MDL 2100)

ZANTAC:

  • In re Zantac (Ranitidine) Prods. Liab. Litig., 9:20-md-2924 (S.D. Fla.) (MDL 2924)

Pharmaceutical Antitrust for Health Plans

When drug manufacturers engage in unlawful anti-competitive practices, such as price-fixing, delaying generic competition, or deceptive marketing, health plans and their members bear the burden in higher health care costs. We help health plans pursue recoveries in pharmaceutical antitrust cases, to recoup the inflated costs caused by unlawful conduct.

Representative Pharmaceutical Antitrust Cases:

AWP LITIGATION: In re Pharmaceutical Industry Average Wholesale Price Litig., 1:01-cv-12257 (D. Mass.) (MDL 1456)

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION: 16-md-2724 (E.D. Pa) (MDL 2724)

FIRST DATABANK/MCKESSON:  New England Carpenters Fund, et al. v. First Databank, Inc., et al, 1:05-cv-11148 (D. Mass.)

HYTRIN: In re Terazosin Hydrochloride Antitrust Litig., 1:99-md-1317 (S.D. Fla.) (MDL 1317)

K-DUR: In re K-Dur Antitrust Litig., 01-cv-1652 (D.N.J.) (MDL 1419)

MYLAN: In re Lorazepam & Clorazepate Antitrust Litig., 1:99-ms-276 (D.D.C.) (MDL 1290)

NEURONTIN: In re: Neurontin Marketing, Sales Practices, and Prods. Liab. Litig., 1:04-cv-10981 (D. Mass.) (MDL 1629)

NEXIUM: 

  • Marketing – Pennsylvania Employees Benefit Trust Fund et al. v. Zeneca Inc. et al., 1:05-cv-00075 (D. Del.)
  • Patent – In re Omeprazole Patent Litig., M-21-81 (S.D.N.Y.) (MDL 1291)

    PAXIL:
  • Antitrust:  Nichols, et al. v. SmithKline Beecham, 00-cv-6222 (E.D. Pa.)
  • Off-label:  Simonet v. SmithKline Beecham, 06-cv-1230 (D.P.R.)
  • Pediatric:  Carpenters and Joiners Welfare Fund, et al. v. SmithKline Beecham, 04-cv-3500 (D. Minn.)

PROVIGIL: In re Modafinil Antitrust Litig., 2:06-cv-01797 (E.D. Pa.)

RELAFEN: In re Relafen Antitrust Litig., 01-cv-12239 (D. Mass.)

REMERON: In re Remeron End-Payor Antitrust Litig., 02-cv-2007 (D.N.J.)

SERONO: Government Employees Hospital Association, et al. v. Serono International, S.A., et al., 05-cv-11935 (D. Mass.)

SYNTHROID: In re Synthroid Marketing Litig., 97-C-6017 (N.D. Ill.) (MDL 1182)

TEPEZZA: In re Tepezza Marketing, Sales, Practices, and Prods. Liab. Litig., 1:23-cv-3568 (N.D. Ill.) (MDL 3079)

TRICOR: In re: TriCor Indirect Purchaser Antitrust Litig., 1:05-cv-00360 (D. Del.)

VYTORIN: In re Vytorin/Zetia Marketing, Sales Practices, and Prods. Liab. Litig. (D.N.J.) (MDL 1938

Contact Us Today